Dr. Alderuccio is a clinical investigator who specializes in the study and treatment of patients with lymphoma. His area of primary research is clinical and translational research in lymphoma. He has a strong interest in indolent and aggressive lymphomas, particularly in the implementation of quantitative FDG-PET/CT analysis in the risk stratification and evaluation of novel therapies in lymphoma patients.

Kat is from Lehi, Utah and is the Health Education Manager for lymphoma. She has worked in healthcare for a decade now, and earned her degree in Community Health Education and Promotion. Kat is passionate about disease prevention as well as improving quality of life and health equity. She enjoys reading, hiking, baking, ice skating, gardening, time with her family and friends, and most of all, spoiling her nieces and nephew.